USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Chi Associates, Inc.
City: Arlington
State: VA
Zip+4: 22201
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $150,000.00 3
SBIR Phase II $993,706.00 2

Award List:

BLOOD MICRO-CULTURE ASSAY OF HORMONE-DEPENDENT PROLIFERATION IN HEMATOLOGIC DISORDERS

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

BLOOD MICRO-CULTURE ASSAY OF HORMONE-DEPENDENT PROLIFERATION IN HEMATOLOGIC DISORDERS

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $493,706.00
Abstract:
In the past 20 years, the progressive ability to grow blood forming cells in tissue culture, has dramatically increased our understanding of blood disorders and has allowed the isolation of many new hemopoietic hormones which may now be used for some of these disorders. nevertheless, until recently,… More

CLINICAL DIAGNOSTIC KIT FOR INHERITED BLOOD DISORDERS

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

CLINICAL DIAGNOSTIC KIT FOR INHERITED BLOOD DISORDERS

Award Year / Program / Phase: 1991 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $500,000.00
Abstract:
Inherited blood disorders are probably the most common single gene disorder. in the past 20 years, the applicationof recombinant dna technology to studies of some common inherited blood disorders has dramatically increased understanding of the molecular mechanisms of these diseases and provided new… More

Hematological Diagnosis of B Thalassemia Mutations

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: Pranee Sutcharitchan
Award Amount: $50,000.00
Abstract:
Beta thalassemia, the most common disease inherited at a single genetic locus, is a major cause of morbidity and mortality in populations having high frequencies of the beta-thalassemia mutations. At this juncture, the mainstays of therapy in afflicted populations consist of population screening,… More